US OptionsDetailed Quotes

ADPT241018P5000

Watchlist

0.30
-0.10-25.00%

15min DelayClose Sep 27 16:00 ET

0.30High0.30Low

Adaptive Biotechnologies Stock Discussion

Jaguar8

Aug 29 07:03

NEWS

$Adaptive Biotechnologies (ADPT.US)$
Adaptive Announces IVDR Certification for clonoSEQ® in European Union
Adaptive Biotechnologies (Nasdaq: ADPT) has announced that its clonoSEQ® test has received In Vitro Diagnostic Regulation (IVDR) 2017/746 Class C certification in the European Union. This makes clonoSEQ the first IVDR-certified test for detecting minimal residual disease (MRD) in patients with lymphoid malignancies. The certification allows for broad use in assessing MRD status and chang...

TechWhiz

Jun 28 18:55

Good volume move up. Small caps like adaptive biotechnologies are moving after Nvidia and other big techs took a break.
Should see higher prices from here.

Trytosaveabit

May 31 06:39

Watching for data outa this!

$Adaptive Biotechnologies (ADPT.US)$ Adaptive Biotechnologies Says Its Next-generation Sequencing-based ClonoSEQ Test For Measurable Residual Disease Assessment Will Be Included In Several Oral And Poster Presentations At American Society Of Clinical Oncology Annual Meeting
The meeting will be taking place from May 31-June 4 in Chicago. Company will also present at the European Hematology Association (EHA) Hybrid Congress taking place June 13-16 in Madrid and virtually...

TechWhiz

May 4 08:24

Adaptive biotech earnings?

Will they be as good as Ardelyx? Hopefully.
Ardelyx price skyrocketed after good earnings. The tide could be turning for biopharm, biotech stocks.

Moomoo AI

Mar 8 04:26

Recent insider selling at Adaptive Biotechnologies and lack of insider buying in the past year may deter potential investors, despite insiders owning significant shares.

Have Adaptive Biotechnologies Insiders Been Selling Stock?

Alvinnnnnnngenius

Nov 7, 2023 06:34

$Adaptive Biotechnologies (ADPT.US)$ Adaptive Biotechnologies Announces New Translational Collaboration to Measure Minimal Residual Disease with clonoSEQ® Assay Across BeiGene's Lymphoid Malignancy Pipeline

Moomoo AI

Oct 27, 2023 07:27

Recent months saw no insider buying and some selling, potentially raising investor concerns. Lack of recent insider buying combined with sales might demand investor caution.

Adaptive Biotechnologies Insiders Sell US$872k Of Stock, Possibly Signalling Caution

Sam Wallstreet

Feb 15, 2023 09:58

QUICK SCALP 10 $ADPT — STOCK & OPTION PLAY
ALERT ON: $10.02
ON THE WATCH: $10.10
🥇 SIGNED OF MORE UPTREND: $10.25
NEED IT TO BREAK OVER: $10.36
key indicator for MORE uptrend: $10.42
confirmation uptrend - $10.63
mini breakout - $10.71. $Adaptive Biotechnologies (ADPT.US)$

Analysts Notebook

Jun 3, 2022 06:30

Columns Top upgrades and downgrades on 6/3

Upgrades
• $Ciena (CIEN.US)$: B.Riley Upgrades to Buy from Neutral - PT $67 (from $65)
• $Ecolab (ECL.US)$: Credit Suisse Upgrades to Outperform from Neutral - PT $195 (from $180)
• $Hersha Hospitality Trust (HT.US)$: Jefferies Upgrades to Buy from Neutral - PT $13 (from $11)
• $Martin Marietta Materials (MLM.US)$: JPMorgan Upgrades to Overweight from Neutral - PT $410 (from $420)
• $Portland General Electric (POR.US)$: Goldman Sachs Upgrades to Buy from Neutral - P...

FiveHundredCents

Mar 15, 2022 05:45

Cathie Wood Watch: Ark Seeks to 3D-Print Investing Profits

$ARK Innovation ETF (ARKK.US)$ $ARK Next Generation Internet ETF (ARKW.US)$ $ARK Autonomous Technology & Robotics ETF (ARKQ.US)$
Investment star Cathie Wood, Chief Executive of Ark Investment Management, continues her buying and selling of stocks -- mostly buying -- amid the equity market’s turmoil.
On Friday, she ventured into 3D printer companies, $Stratasys (SSYS.US)$ and $Velo3D (VLD.US)$. Ark also continued its foray into biotechnology stoc...

No comment yet